Study of gene expression profiles in TK6 human cells exposed to DNA-oxidizing agents

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 689, Issue 1-2, 2010, Pages 21-49

  Platel, Anne ^a,b,c   Gervais, Véronique ^a   Sajot, Nicolas ^a   Nesslany, Fabrice ^b,c   Marzin, Daniel ^b,c   Claude, Nancy ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b UNIV LILLE   (France)

^c IPL   (France)

Author keywords

Mechanistic toxicogenomics; Microarray; Oxidative stress; TK6 human lymphoblastoid cells

Indexed keywords

DNA OXIDIZING AGENT; GLUCOSE OXIDASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; OXIDIZING AGENT; POTASSIUM BROMATE; PROTEIN P53; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL CYCLE ARREST; CELL DEATH; CELLULAR STRESS RESPONSE; CHROMOSOME ABERRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA REPAIR; GENE EXPRESSION PROFILING; GENE TARGETING; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LYMPHOBLASTOID CELL LINE; MICROARRAY ANALYSIS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BROMATES; CELL CYCLE; CELL DEATH; CELL LINE; DNA; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; HUMANS; HYDROGEN PEROXIDE; LIPID METABOLISM; LYMPHOCYTES; MICROARRAY ANALYSIS; OXIDANTS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 77953913296     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2010.04.004     Document Type: Article

References (55)

1. Kirsch-Volders M., Gonzalez L., Carmichael P., Kirkland D. Risk assessment of genotoxic mutagens with thresholds: a brief introduction. Mutat. Res. 2009, 678:72-75.
2. Nohmi T., Toyoda-Hokaiwado N., Yamada M., Masumura K., Honma M., Fukushima S. International symposium on genotoxic and carcinogenic thresholds. Genes Environ. 2008, 30:101-107.
3. Elhajouji A., Van Hummelen P., Kirsch-Volders M. Indications for a threshold of chemically-induced aneuploidy in vitro in human lymphocytes. Environ. Mol. Mutagen. 1995, 26:292-304.
4. Lynch A., Harvey J., Aylott M., Nicholas E., Burman M., Siddiqui A., Walker S., Rees R. Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity. Mutagenesis 2003, 18:345-353.
5. Pratt I.S., Barron T. Regulatory recognition of indirect genotoxicity mechanisms in the European Union. Toxicol. Lett. 2003, 140-141:53-62.
6. Kirsch-Volders M., Vanhauwaert A., Eichenlaub-Ritter U., Decordier I. Indirect mechanisms of genotoxicity. Toxicol. Lett. 2003, 140-141:63-74.
7. Nakae D., Wanibuchi H., Konishi Y., Fukushima S. Possible involvement of adaptation mechanisms in the achievement of an ineffective dose range for the carcinogenicity of genotoxic carcinogens. Genes Environ. 2008, 30:125-131.
8. Doak S.H., Jenkins G.J., Johnson G.E., Quick E., Parry E.M., Parry J.M. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res. 2007, 15:3904-3911.
9. Doak S.H., Brüsehafer K., Dudley E., Quick E., Johnson G., Newton R.P., Jenkins G.J. No-observed effect levels are associated with up-regulation of MGMT following MMS exposure. Mutat. Res. 2008, 648:9-14.
10. L. Müller, E. Gocke, T. Lavé, T. Pfister, Ethyl methanesulfonate toxicity in Viracept-A comprehensive human risk assessment based on threshold data for genotoxicity, Toxicol. Lett. 190 (2009) 317-329.
11. Platel A., Nesslany F., Gervais V., Marzin D. Study of oxidative DNA damage in TK6 human lymphoblastoid cells by use of the in vitro micronucleus test: determination of no-observed-effect levels. Mutat. Res. 2009, 678:30-37.
12. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell. Biol. 2007, 39:44-84.
13. Martindale J.L., Holbrook N.J. Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol. 2002, 192:1-15.
14. Allen R.G., Tresini M. Oxidative stress and gene regulation. Free Radic. Biol. Med. 2000, 28:463-499.
15. Scandalios J.G. Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz. J. Med. Biol. Res. 2005, 38:995-1014.
16. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160:1-40.
17. Limón-Pacheco J., Gonsebatt M.E. The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mutat. Res. 2009, 674:137-147.
18. Kirkland D.J. In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results. Mutagenesis 2007, 22:161-175.
19. Aubrecht J., Caba E. Gene expression profile analysis: an emerging approach to investigate mechanisms of genotoxicity. Pharmacogenomics 2005, 6:419-428.
20. Ellinger-Ziegelbauer H., Aubrecht J., Kleinjans J.C., Ahr H.J. Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity. Toxicol. Lett. 2009, 186:36-44.
21. Thybaud V., Le Fevre A.C., Boitier E. Application of toxicogenomics to genetic toxicology risk assessment. Environ. Mol. Mutagen. 2007, 48:369-379.
22. Ellinger-Ziegelbauer H., Fostel J.M., Aruga C., Bauer D., Boitier E., Deng S., Dickinson D., Le Fevre A.C., Fornace A.J., Grenet O., Gu Y., Hoflack J.C., Shiiyama M., Smith R., Snyder R.D., Spire C., Tanaka G., Aubrecht J. Characterization and interlaboratory comparison of a gene expression signature for differentiating genotoxic mechanisms. Toxicol. Sci. 2009, 110:341-352.
23. Fabre N., Anglade I., Vericat J.A. Application of toxicogenomic tools in the drug research and development process. Toxicol. Lett. 2009, 186:13-17.
24. Suter L., Babiss L., Wheeldon E. Toxicogenomics in predictive toxicology in drug development. Chem. Biol. 2004, 11:161-171.
25. Skopek T.R., Liber H.L., Penman B.W., Thilly W.G. Isolation of a human lymphoblastoid line heterozygous at the thymidine kinase locus: possibility for a rapid human cell mutation assay. Biochem. Biophys. Res. Commun. 1978, 84:411-416.
26. Chipman J.K., Parsons J.L., Beddowes E.J. The multiple influences of glutathione on bromate genotoxicity: implications for the dose-response relationship. Toxicology 2006, 221:187-189.
27. Kawanishi S., Murata M. Mechanism of DNA damage induced by bromate differs from general types of oxidative stress. Toxicology 2006, 221:172-178.
28. Luan Y. Potassium bromate treatment predominantly causes large deletions, but not GC>TA transversion in human cells. Mutat. Res. 2007, 619:113-123.
29. 2. Free Radic. Biol. Med. 2002, 33:691-702.
30. Bjelland S., Seeberg E. Mutagenicity, toxicity and repair of DNA base damage induced by oxidation. Mutat. Res. 2003, 531:37-80.
31. Cadet J., Douki T., Gasparutto D., Ravanat J.L. Oxidative damage to DNA: formation, measurement and biochemical features. Mutat. Res. 2003, 531:5-23.
32. Borenfreund E., Babich H., Martin-Alguacil N. Comparison of two in vitro cytotoxicity assays: the neutral red (NR) and tetrazolium MTT tests. Toxicol. In Vitro 1988, 2:1-6.
33. MAQC Consortium (L. Shi et al.), The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements, Nat. Biotechnol. 24 (2006) 1151-1161.
34. Applied Biosystems, Relative quantitation of gene expression, User bulletin No. 2. ABI prism 7700 Sequence Detection System, http://www3.appliedbiosystems.com/cms/groups/mcb_support/documents/generaldocuments/cms040980.pdf.
35. Akerman G.S., Rosenzweig B.A., Domon O.E., Tsai C.A., Bishop M.E., McGarrity L.J., Macgregor J.T., Sistare F.D., Chen J.J., Morris S.M. Alterations in gene expression profiles and the DNA-damage response in ionizing radiation-exposed TK6 cells. Environ. Mol. Mutagen 2005, 45:188-205.
36. Seidel S.D., Kan H.L., Stott W.T., Schisler M.R., Gollapudi B.B. Identification of transcriptome profiles for the DNA-damaging agents bleomycin and hydrogen peroxide in L5178Y mouse lymphoma cells. Environ. Mol. Mutagen 2003, 42:19-25.
37. Akerman G.S., Rosenzweig B.A., Domon O.E., McGarrity L.J., Blankenship L.R., Tsai C.A., Culp S.J., MacGregor J.T., Sistare F.D., Chen J.J., Morris S.M. Gene expression profiles and genetic damage in benzo(a)pyrene diol epoxide-exposed TK6 cells. Mutat. Res. 2004, 549:43-64.
38. Islaih M., Halstead B.W., Kadura I.A., Li B., Reid-Hubbard J.L., Flick L., Altizer J.L., Thom Deahl J., Monteith D.K., Newton R.K., Watson D.E. Relationships between genomic, cell cycle, and mutagenic responses of TK6 cells exposed to DNA damaging chemicals. Mutat. Res. 2005, 578:100-116.
39. Budanov A.V., Sablina A.A., Feinstein E., Koonin E.V., Chumakov P.M. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 2004, 304:596-600.
40. Liu B., Chen Y., St.Clair D.K. ROS and p53: A versatile partnership. Free Radic. Biol. Med. 2008, 44:1529-1535.
41. Xie L., Pandey R., Xu B., Tsaprailis G., Chen Q.M. Genomic and proteomic profiling of oxidative stress response in human diploid fibroblasts. Biogerontology 2009, 10:125-151.
42. Crosby L.M., Hyder K.S., DeAngelo A.B., Kepler T.B., Gaskill B., Benavides G.R., Yoon L., Morgan K.T. Morphologic analysis correlates with gene expression changes in cultured F344 rat mesothelial cells. Toxicol. Appl. Pharmacol. 2000, 169:205-221.
43. Islaih M., Li B., Kadura I.A., Reid-Hubbard J.L., Deahl J.T., Altizer J.L., Watson D.E., Newton R.K. Comparison of gene expression changes induced in mouse and human cells treated with direct-acting mutagens. Environ. Mol. Mutagen. 2004, 44:401-419.
44. Amundson S.A., Lee R.A., Koch-Paiz C.A., Bittner M.L., Meltzer P., Trent J.M., Fornace A.J. Differential responses of stress genes to low dose-rate gamma irradiation. Mol. Cancer Res. 2003, 1:445-452.
45. Han E.S., Muller F.L., Pérez V.I., Qi W., Liang H., Xi L., Fu C., Doyle E., Hickey M., Cornell J., Epstein C.J., Roberts L.J., Van Remmen H., Richardson A. The in vivo gene expression signature of oxidative stress. Physiol. Genomics 2008, 34:112-126.
46. Morgan K.T., Ni H., Brown H.R., Yoon L., Qualls C.W., Crosby L.M., Reynolds R., Gaskill B., Anderson S.P., Kepler T.B., Brainard T., Liv N., Easton M., Merrill C., Creech D., Sprenger D., Conner G., Johnson P.R., Fox T., Sartor M., Richard E., Kuruvilla S., Casey W., Benavides G. Application of cDNA microarray technology to in vitro toxicology and the selection of genes for a real-time RT-PCR-based screen for oxidative stress in Hep-G2 Cells. Toxicol. Pathol. 2002, 30:435-451.
47. Amundson S.A., Khanh T.D., Vinikoor L., Koch-Paiz C.A., Bittner M.L., Trent J.M., Meltzer P., Fornace A.J. Stress-specific signatures: expression profiling of p53 wild-type and -null human cells. Oncogene 2005, 24:4572-4579.
48. Kowaltowski A.J., Vercesi A.E. Mitochondrial damage induced by conditions of oxidative stress. Free Rad. Biol. Med. 1999, 26:463-471.
49. Yang N., Chaudhry M.A., Wallace S.S. Base excision repair by hNTH1 and hOGG1: A two edged sword in the processing of DNA damage in γ-irradiated human cells. DNA Repair 2006, 5:43-51.
50. Collis S.J., Schwaninger J.M., Ntambi A.J., Keller T.W., Nelson W.G., Dillehay L.E., Deweese T.L. Evasion of early cellular response mechanisms following low level radiation-induced DNA damage. J. Biol. Chem. 2004, 279:49624-49632.
51. Rothkamm K., Löbrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc. Natl. Acad. Sci. U.S.A. 2003, 10:5057-5062.
52. Hendry J.H., West C.M.L. Apoptosis and mitotic cell death: their relative contribution to normal tissue and tumour radiation response. Int. J. Radiat. Biol. 1997, 71:709-719.
53. Marnett L.J. Oxy radicals, lipid peroxidation and DNA damage. Toxicology 2002, 181-182:219-222.
54. Heinloth A.N., Shackelford R.E., Innes C.L., Bennett L., Li L., Amin R.P., Sieber S.O., Flores K.G., Bushel P.R., Paules R.S. Identification of distinct and common gene expression changes after oxidative stress and gamma and ultraviolet radiation. Mol. Carcinogen. 2003, 37:65-82.
55. Zschenker O., Borgmann K., Streichert T., Meier I., Wrona A., Dikomey E. Lymphoblastoid cell lines differing in p53 status show clear differences in basal gene expression with minor changes after irradiation. Radiother. Oncol. 2006, 80:236-249.